VIRX (viracta.com) Earnings per share growth rate in current year

VIRX (Viracta Therapeutics) - company brandmark

Is it worth investing in a business that minimizes capital expenditures through the full outsourcing of production and testing? The annual EPS growth trend provides the answer, and 0.00 shows the current value of the metric. Viracta Therapeutics (VIRX) is accelerating therapy approval through synergy with oncology networks, while simultaneously implementing software robots for lymphoma data analysis.

VIRX: Viracta Therapeutics Earnings growth in current year 07/04/2022 - 02/16/2025

Financial and market metric breakdowns for Viracta Therapeutics, Inc. (VIRX)

Fundamental valuation:VIRX, Viracta Therapeutics, Inc.
Manufactured products of viracta.com

Conservative capital demands maximum cash flow transparency and stability of fundamental indicators. This metric measures the annual dynamics of earnings per share, allowing for an assessment of the real efficiency of business capitalization without reporting time lags. For Viracta Therapeutics (VIRX), which is focused on launching a lymphoma drug and seeking partners, the annual EPS growth trend serves as an indicator of the market consensus regarding the value of its intellectual assets.

Key competitors

Earnings per share growth rate in current year BeiGene Corp (ONC)|HALO (Halozyme Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year revmed.com RVMD|Earnings growth in current year AAPG|Net earnings per share growth this year CG Oncology CGON|Earnings per share growth in current year UroGen URGN|Expected net earnings per share growth this year Bicara Bio (BCAX)|PSNL - Earnings per share growth in current year|ERAS - Earnings growth in current year|DCTH: Earnings growth in current year|Y-mAbs Therapeutics, Inc. (YMAB) - Earnings growth in current year|Net earnings per share growth this year AURA|Earnings per share growth rate in current year candeltx.com CADL|Earnings growth in current year ARAY|SLS (SELLAS Life Sciences Group, Inc.) - Earnings per share increase in current year|Earnings growth in current year ACTU (Actuate Therapeutics Inc)|Earnings per share increase in current year CTOR|tuhurabio.com - Earnings growth in current year|Earnings per share increase in current year TARA (Protara Therapeutics)|Fate Therapeutics, Inc. (FATE) - Earnings per share growth in current year|WHWK - Expected net earnings per share growth this year|Earnings per share growth in current year tscan.com|CSBR: Earnings per share increase in current year|Earnings per share growth in current year XBiotech USA (XBIT)|CVM: Earnings per share trend in current year|Earnings per share growth in current year ostherapies.com OSTX|Net earnings per one share growth for the current year RADX (Radiopharm Theranostics Limited)|Artiva - Earnings growth in current year|ANL: Earnings per share growth in current year|VERU: Earnings growth in current year|Earnings per share trend in current year TPST (Tempest Tx)|XLO (Xilio Therapeutics) - Earnings growth in current year|Earnings per share growth rate in current year renovarobio.com RENB|Earnings per share growth in current year muraloncology.com (MURA)|Net earnings per one share growth for the current year KAPA|Earnings growth in current year OKUR (onkuretherapeutics.com)|Net earnings per one share growth for the current year GDTC (CytoMed)|Curis - Earnings growth in current year|APLM: Earnings per share growth in current year|Tharimmune (THAR) - Earnings per share growth in current year|Net earnings per share growth this year Advanced Biomed Inc.|GNPX (Genprex Inc) - Earnings growth in current year|Calidi Biotherapeutics (CLDI) - Expected net earnings per share growth this year|Earnings growth in current year SBFM|Earnings per share growth in current year XBIO (Xenetic Biosciences, Inc.)|Earnings growth in current year SLRX (salariuspharma.com)|PPBT - Net earnings per share growth this year|AONC - Earnings per share growth in current year|Earnings per share increase in current year BGNE (BeOne Medicines)|CKPT: Earnings growth in current year|Elevation Oncology Inc. (ELEV) - Earnings growth in current year|ICAD (iCAD) - Earnings growth in current year|Earnings growth in current year ikenaoncology.com|Earnings growth in current year NTBL|Net earnings per share growth this year MorphoSys Corporation MOR|NAYA Biosciences - Net earnings per share growth this year|Net earnings per share change in current year Ascentage Pharma